U.S. medical scientists have discovered a technique that might allow them to control drug-resistant bacteria.
The Harvard Medical School researchers discovered certain combinations of antibiotics favor the growth of non-resistant strains at the expense of resistant ones. That finding might help combat the spread of such microbes, as well as shed light on microbial ecology and evolution.
Roy Kishony, an assistant professor of systems biology, and colleagues discovered that antagonistic drug combinations, in which the drugs' cumulative effects are less than when they are given separately, show such properties. At sub-lethal concentrations a mixture of doxycycline and ciprofloxacin preferentially selects for wild-type Escherichia coli bacteria over that of a doxycyline-resistant strain in a laboratory culture.
The finding, said Kishony, is surprising and counter-intuitive, since the use of antibiotic drugs is responsible for the generation and selection of resistant bacterial pathogen strains. But the study showed that with the right combinations and concentrations, non-resistant bacterial strains can be selected.
The research is detailed in this week's issue of the journal Nature.
Copyright 2007 by United Press International
Related stories:
Tomato stands firm in face of fungus
Scientists at the University of Amsterdam have discovered how to keep one’s tomatoes from wilting – the answer lies at the molecular level. The story of how the plant beat the pathogen, and what it means for combating other plant diseases, is published May 9th in the open-access journal
PLoS Pathogens.
New vaccine may give long-term defense against deadly bird flu and its variant forms
A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.
How the plant immune system can drive the formation of new species
Plant geneticists know that not all plants from the same species can be successfully bred. Apparently, there are reproductive barriers that not only prevent the exchange of genes between well-established species (which goes to the very definition of a species), but also between varieties of one and the same species. How these barriers arise is of central importance if one wants to understand the origin of biodiversity.
Anti-microbial 'grammar' may mean new medicines
In most languages, sentences only make sense if the words are placed in the right order. Now, MIT researchers and an IBM colleague have used grammatical principles to help their search for new antimicrobial medicines.
'Coinage' of plankton -- viruses
Sea experiments show there's a constant shuffling of genetic endowments among tiny plankton, say Massachusetts Institute of Technology researchers.
New antibiotic beats superbugs at their own game
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for the great majority of staphylococcal infections worldwide, both in hospitals and in the community.
Researchers identify potential new drug candidates to combat 'bird flu'
As the specter of a worldwide outbreak of avian or "bird flu" lingers, health officials recognize that new drugs are desperately needed since some strains of the virus already have developed resistance to the current roster of anti-flu remedies.
Novel compound may treat acute diarrhea
In a development that may lessen the epidemic of diarrhea-related deaths among children in developing countries, scientists in the laboratory of Nobel Laureate Ferid Murad, M.D., Ph.D., at The University of Texas Health Science Center at Houston have discovered a novel compound that might lead to an inexpensive, easy-to-take treatment. The results of pre-clinical tests appear in the June 16 online edition of the journal
Proceedings of the National Academy of Sciences of the United States of America.